Skip to main navigation

Skip to content
Skip to primary sidebar
Skip to footer

240.243.1201
info@glycomimetics.com

Careers
Contact Us

Investor Relations

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
  - Sickle Cell Disease
Technology & Publications
Collaborations
Investors

PRESS RELEASES

Investor Relations

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
  - Sickle Cell Disease
Technology & Publications
Collaborations
Investors

PRESS RELEASES

Year

November 24, 2021

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

November 23, 2021

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial in China of GlycoMimetics’ Uproleselan for the Treatment of AML

November 22, 2021

GlycoMimetics Appoints Regulatory Veteran Lisa DeLuca as Vice President, Regulatory Affairs

November 15, 2021

GlycoMimetics Completes Enrollment of Phase 3 Registration Trial Evaluating Lead Candidate Uproleselan in Patients with Relapsed /Refractory Acute Myeloid Leukemia (AML)

November 11, 2021

GlycoMimetics GMI-1359 Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

November 9, 2021

GlycoMimetics to Present at Two Upcoming Healthcare Investor Conferences

November 2, 2021

GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2021

October 26, 2021

GlycoMimetics to Report Third Quarter Financial Results on November 2, 2021

September 23, 2021

Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug Uproleselan Published in BLOOD

September 8, 2021

GlycoMimetics to Present at Upcoming H.C. Wainwright & Co Annual Global Investment Virtual Conference

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 29

Shareholder Tools

Print

Print
Printed Materials

Printed Materials
Email Alerts

Email Alerts
RSS

RSS
Search

Search

Footer

Questions?

Contact GlycoMimetics Today

Get in Touch

©2021 GlycoMimetics All rights reserved. Website Design & Development: Graphic Beans

Site Map | Terms of Use | Privacy | Contact Us